Therapeutic Treatment of Gingivitis: No Longer a Loss Leader
DiGangi, P.
Journal-Oklahoma Dental Association 107(6): 41
2016
ISSN/ISBN: 0164-9442 PMID: 29782114 Document Number: 690655
Document emailed within 1 workday
Related Documents
Peota, C. 2006: Loss leader Minnesota Medicine 89(10): 26-29McClanahan, S.F.; Bartizek, R.D. 2002: Effects of triclosan/copolymer dentifrice on dental plaque and gingivitis in a 3-month randomized controlled clinical trial: influence of baseline gingivitis on observed efficacy Journal of Clinical Dentistry 13(4): 167-178
Krajcovicova, Z.; Melus, V.; Zigo, R.; Matisakova, I.; Vecera, J.; Kralova, E. 2019: Hyperbaric oxygen therapy in treatment of sudden sensorineural hearing loss: finding for the maximal therapeutic benefit of different applied pressures Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 46(5): 665-672
Chen, J.T.; Tatsuki, Y.; Hirai, Y.; Hasumi, K. 1993: Increase in CDDP therapeutic index by lower concentration and longer infusion time--home chemotherapy for ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(2): 265-270
Jansa, P.; Pastrnák, A. 1974: Regression of gingivitis following local treatment Ceskoslovenska Patologie 10(2): 102-105
Reid, P.C.; Virtanenkari, S. 2005: Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia : a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts Bjog (Oxford. Print) 112(8): 1121-1125
Rateitschak, D.H. 1972: Comparitive studies of hand instruments and cavitron in the treatment of gingivitis Deutsche Zahnarztliche Zeitschrift 27(4): 310
Rateitschak, D.H. 1972: Comparitive studies of hand instruments and cavitron in the treatment of gingivitis Deutsche Zahnarztliche Zeitschrift 27(4): 310
Sadek, S.I.; El-Ashiry, G. 1979: A single dose oral tinidazole for the treatment of acute necrotizing ulcerative gingivitis Egyptian Dental Journal 25(3): 231-239
Martos, Jé.; Ahn Pinto, K.Von.; Feijó Miguelis, T.Martins.; Cavalcanti, Mília.Cabral.; César Neto, Jão.Batista. 2019: Clinical treatment of necrotizing ulcerative gingivitis: a case report with 10-year follow-up General Dentistry 67(3): 62-65
Israeli, A.; Liebergal, M.; Friedman, J.B.; Segal, D. 1996: Osteoarthritis, the hazard of living longer: arthroscopy vs. conservative treatment Israel Journal of Medical Sciences 32(2): 121-122
Campos-Outcalt, D. 2007: Practice alert: CDC no longer recommends quinolones for treatment of gonorrhea Journal of Family Practice 56(7): 554-558
Preisinger, E.; Alacamlioglu, Y.; Pils, K.; Saradeth, T.; Schneider, B. 1995: Therapeutic exercise in the prevention of bone loss. A controlled trial with women after menopause American Journal of Physical Medicine and Rehabilitation 74(2): 120-123
Jensen, G.F.; Meinecke, B.; Boesen, J.; Transbøl, I. 1985: Does 1,25(OH)2D3 accelerate spinal bone loss? a controlled therapeutic trial in 70-year-old women Clinical Orthopaedics and Related Research 192: 215-221
Soboleva, L.A.; Shul'dyakov, A.A.; Bulkina, N.V. 2015: Efficacy of Cycloferon Liniment in the Combined Treatment of Chronic Gingivitis in Patients with Chronic Infectious Diseases Eksperimental'naia i Klinicheskaia Farmakologiia 78(7): 41-44
Cozanitis, D.A. 1977: Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine) Der Anaesthesist 26(12): 649-650
Shaw, N.; Trepanier, L.A.; Center, S.A.; Garland, S. 1996: High dietary chloride content associated with loss of therapeutic serum bromide concentrations in an epileptic dog Journal of the American Veterinary Medical Association 208(2): 234-236
Bourde, J.; Assadourian, R.; Raynaud, B.; Houze, J.P.; Randrianonimandimby, J.; Lamy, J. 1972: Hemorrhages from duodenal ulcers. Etiological and therapeutic considerations. (Apropos of 133 cases of moderate and extensive loss) Journal de Chirurgie 103(5): 465-478
Merino, J.J.; Montes, M.L.; Blanco, A.; Bustos, M.J.; Oreja-Guevara, C.; Bayon, C.; Cuadrado, A.; Lubrini, G.; Cambron, I.; Munoz, A.; Cebolla, S.; Gutierrez-Fernandez, M.; Bernardino, J.I.; Arribas, J.R.; Fiala, M. 2011: HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system Revista de Neurologia 52(2): 101-111
Staehelin, C.; Keiser, O.; Calmy, A.; Weber, R.; Elzi, L.; Cavassini, M.; Schmid, P.; Bernasconi, E.; Furrer, H.; Barth, J.; Battegay, M.; Bernasconi, E.; Böni, J.; Bucher, H.C.; Bürgisser, P.; Burton-Jeangros, C.; Calmy, A.; Cavassini, M.; Dubs, R.; Egger, M.; Elzi, L.; Fehr, J.; Fischer, M.; Flepp, M.; Francioli, P.; Furrer, H.; Fux, C.A.; Gorgievski, M.; Günthard, H.; Hasse, B.; Hirsch, H.H.; Hirschel, B.; Hösli, I.; Kahlert, C.; Kaiser, L.; Keiser, O.; Kind, C.; Klimkait, T.; Kovari, H.; Ledergerber, B.; Martinetti, G.; Martinez de Tejada, B.; Müller, N.; Nadal, D.; Pantaleo, G.; Rauch, A.; Regenass, S.; Rickenbach, M.; Rudin, C.; Schmid, P.; Schultze, D.; Schöni-Affolter, F.; Schüpbach, J.; Speck, R.; Taffé, P.; Telenti, A.; Tr 2012: Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study Journal of Acquired Immune Deficiency Syndromes 59(1): 79-85